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Abstract
Multi-Frequency Processing for Lumen Enhancement with Wideband Intravascular
Ultrasound
Rory Allen Carrillo

The application of high frequency ultrasound is the key to higher resolution intravascular
ultrasound (IVUS) images. The need to further improve the IVUS spatial resolution may
drive the transducer center frequency even higher than the current 40 MHz range.
However, increasing the center frequency may be challenging as it leads to stronger
scattering echoes from blood. The high level of blood scattering echoes may obscure the
arterial lumen and make image interpretation difficult. Blood backscatter levels increase
with transmission center frequency at a much greater rate compared to arterial tissue.
These different frequency dependencies provide a potential method to distinguish blood
from tissues by means of multi-frequency processing techniques. To obtain a good bloodtissue contrast with sufficient signal-to-noise ratio, a system with a wider bandwidth is
highly desirable. The method described in this paper is based on the ratio of the received
signal power between the high (60 MHz) and low (25 MHz) frequency ranges from a
novel 40 MHz wideband IVUS catheter. In this paper we will present our in vitro
experiment work on porcine blood and a tissue-mimicking arterial wall. Results of multifrequency processing indicate that blood, at higher frequencies, has a greater backscatter
power that is 8X greater than arterial tissue, suggesting this technique will provide a
greater contrast between the blood-wall lumen boundary for coronary imaging.
.
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Chapter 1: Introduction

Chapter 1: Introduction
According to the American Heart Association (AHA), in 2004 an estimated 79
million American adults (1 in 3) suffered from Cardiovascular Diseases (CVD) and
approximately 871,000 lives were taken. Subsequently, Coronary Heart Disease (CHD)
caused 1 of every 5 deaths in the U.S. in 2004. About every 26 seconds, an American
will suffer from a coronary attack, and about every minute someone will die from one.
CHD is the single largest killer of Americans [1] .
In order to assess the nature of cardiovascular diseases in patients and provide
sound feedback on the appropriate therapeutic interventions, it is necessary to develop
techniques that are capable of evaluating cardiovascular morphology. Until the end of
the 20st century, coronary angiography was the principal method for assessment of the
presence and severity for both peripheral and coronary artery disease. However,
angiography has several limitations in underestimating the disease severity in vessels due
to its silhouette like view of the coronary artery [2;3].
Over the last 20 years, one major minimally invasive diagnostic technique has
proven to be capable of defining cardiac morphology and functionality with great
accuracy. The technique known as Intravascular Ultrasound (IVUS) provides physicians
with something other diagnostic techniques do not, higher-resolution tomographic
images. However, IVUS does not stand on its own. IVUS can provide physicians with a
greater insight into a patient’s physiological nature when used in parallel with
Angiography.
Intravascular Ultrasound and coronary angiography (also known as X-ray
Fluoroscopy) attempt to alleviate the above statistics by combining an imaging modality
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that provides high-resolution, accurate cross-sectional measurements of lesion
morphology, and a contrast technique to reveal potential lesions within the coronary
arteries. Both techniques are combined and necessary in order to properly assess the
severity and progression of coronary artery disease in patients, better helping physicians
with proper diagnostic evaluations and interventional assessments.

1.1 Background
The following sections will encompass all that is related to Intravascular
Ultrasound, including: the circulatory system, coronary arteries, atherosclerosis, coronary
artery disease, imaging modalities and their limitations, and finally, the history of
Intravascular Ultrasound.

1.1.1 The Circulatory System
The human circulatory system consists of the heart, blood, veins, arteries and
capillaries. The main function of the cardiovascular system is to deliver oxygen and
nutrients to all tissues in the body and collect metabolic waste. Blood is a carrier for
hormones and plays an important role in the immune system. The heart is the muscular
organ which pumps blood. The right ventricle pumps deoxygenated blood into the
pulmonary arteries, which carry the blood to the lungs, where it passes through a
capillary network that enables the release of carbon dioxide and the uptake of oxygen.
Oxygenated blood from the lungs returns to the heart via the pulmonary veins, and then
flows from the left atrium into the left ventricle, which pumps blood through the aorta,
the major artery that supplies blood to the body [4;5].
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1.1.2 Coronary Arteries
The arteries that supply the heart muscle, or myocardium, with blood are the
coronary arteries. These arteries are capable of maintaining blood flow at levels
appropriate to the needs of the myocardium. There are two main coronary arteries; the
left coronary artery (LCA) and the right coronary artery (RCA) – see Figure 1 below.
The LCA arises from the aorta and bifurcates into the left anterior descending (LAD)
artery and the left circumflex artery (LCX). Coronary arteries have an open space, also
known as the lumen, through which blood flows with diameters ranging from 2 to 4 mm
[4].

Figure 1: Drawings of coronary arteries and a cross-section of the heart. [Image provided Boston
Scientific]

Normal arterial wall consists of three layers: intima, media, and adventitia. The
intima is the innermost layer that consists of a permeable endothelial cell layer separating
the blood from the vessel wall (roughly 50-150 µm). The internal elastic lamina separates
the intima from the media and reduces turbulence of the flow of blood allowing it to be
pumped farther. The media, which consist of smooth muscle cells, is the middle layer and
3
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is approximately 200-300 µm and are used to contract or relax the to constrict or dilate
the artery to enable blood flow management. The outermost layer, the adventitia, contains
smooth muscle cells mixed with fibrous connective tissue and is known to act as a barrier
from surrounding tissue.

1.1.3 Atherosclerosis
Atherosclerosis is a disease within the blood vessels. The early atherosclerotic
lesion is associated with endothelial cell dysfunction. Cholesterol is delivered by lowdensity lipoproteins (LDL) through the endothelial cells into the intima, where fatty
deposits build up on the inside of the arterial wall [6]. This process causes monocytes, a
type of white blood cell, to enter the intima and eventually turn into inflammatory cells
called macrophages. Macrophages ingest oxidized cholesterol, delivered by the LDL, and
slowly turn into large “foam cells.” Foam cells eventually die and further propagate the
inflammatory process. Over a period of time, these foam cells develop into
atherosclerotic lesions and increase in thickness. These atherosclerotic lesions, also
known as plaques, initially expand into the arterial wall [7]. Intracellular microcalcification deposits form within vascular smooth muscle cells of the surrounding
muscular layer, specifically in the muscle cells adjacent to the lesions. In time, as cells
die, this leads to extracellular calcium deposits between the muscular wall and outer
portion of the athersclerotic plaques. Plaques within the vessel wall are soft. The
progressive plaques consist of fibrotic material or lipids (atheroma), cell debris, calcium
crystals and fibrotic material covered by a thin cap (micron range) that has been formed
by new connective tissue (fibroatheromas). During the progressive disease process, these
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fibroatheromas initially do not restrict the lumen, because of outward remodeling of the
vessel. However, in late stages, typically after decades, these fibroatheromas could
expand into the lumen, narrowing the opening of the vessel and therefore reduce blood
flow. Narrowing of a vessel is called a stenosis. The vasa vasorum are small microvessels
within the adventitia of larger arteries (e.g. coronary arteries) that supply the walls of
these arteries with nutrients. Vasa vasorum are assumed to play an important role in the
generation of atherosclerotic plaque. [8;8]

1.1.4 Coronary Artery Diseases (CAD)
Coronary Artery Disease, a type of CHD, is the result of the accumulation of
atheromatous plaques, or atherosclerosis, specifically within the walls of the coronary
arteries that supply the muscle of the heart with oxygen and nutrients. The accumulation
of plaque on the inner walls of the arteries causes the arteries to harden and narrow;
arteries are normally smooth and elastic. As the plaque continues to build up, less blood
can flow through the arteries, depriving the heart muscles of the oxygen necessary to
function properly, which is called ischemia. Oxygen deprivation to the myocardial
muscle fibers can lead to angina (chest pain) or in an extreme case, myocardial infarction
(heart attack). Figure 2 provides an overview of the progress of CAD as described in the
previous section (see 1.1.3 Atherosclerosis). According to the American Heart
Association in 2007, it was reported that Coronary Artery Disease was the most common
type of heart disease and was the leading cause of death in the United States among men
and women [1;9].
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Figure 2: Progress of Coronary Artery Disease

Much effort has been performed in order to minimize CAD. As a result of numerous
efforts, many diagnostic methods have been developed to aid physicians in the proper
diagnosis of the disease that has and will continue to claim the lives of millions every
year [1]. Intravascular Ultrasound and many other imaging modalities have been design
to help physicians; however, each has their advantages and disadvantages. Currently,
Intravascular Ultrasound has been the leading adjunct technology aiding physicians with
determining the severity of diseases such as CAD [10].

1.1.5 Coronary Imaging Techniques
Cardiac catheterization was first described by Forsmann in 1929 [11], and in 1959
it was developed by Sones [12;13], then modified by Judkins in 1967 [14]. Since then,
cardiac catheterization has become the technique of choice to assess a patient with
6
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coronary disease. Cardiac catheterization is simply a procedure that examines the blood
flow to the heart and tests how well the heart is pumping. During the procedure, a
physician inserts a catheter, or a thin plastic tube, into an artery of the arm or leg. From
there the catheter is advanced into the chambers of the heart or into the coronary arteries
where it can be used to monitor blood pressure, inject a dye for coronary angiography
procedures, or even inflate a balloon to open up the arteries (this is known as Coronary
Angioplasty). When assessing a patient for CAD, cardiac catheterization remains to be
the only clinically accepted method to determine the presence and severity of CAD
despite its costs as an estimated 2 million procedures were performed in 2000 [15]. Great
strides have been made to enhance the ability to visualize the lumen of the coronary
artery but all modalities have their limitations. The following section describes a few of
the cardiac imaging modalities used for coronary artery assessment.
Despite the many noninvasive techniques that can be used to help a physician
diagnose a patient, the ability to insert a catheter within the vessel still has greater
advantages as a diagnostic tool for clinical decision-making as it provides an inside look
to what is physiologically occurring within the vessel. The number of catheterizations
performed has continued to increase each year, proving to be the diagnostic tool of choice
for cardiologists [15].

Coronary Angiography
Coronary angiography is defined as the graphic visualization of the coronary
vessels after the injection of contrast media where the images are recorded for future
review with X-ray technology [16]. The femoral or brachial arteries are used for
catheterization of coronary catheters which distribute the dye, or a contrast media, into
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the coronary vessels. The dye (a radio-opaque contrast agent) is visible by X-ray, and as
the dye is being injected into the vessel, X-rays are being generated and captured to
visually capture on a monitor how the dye is flowing through the vessels of the heart.
This typically helps physicians identify and locate where there is an occlusion within the
heart. Figure 3 is a Coronary Angiography, or X-ray image that captures the dye as it
flows through the coronary arteries. This X-ray image of the contrast agent within the
blood of the coronary arteries allows visualization of the size of the artery lumen. This
information allows physicians to determine if a coronary disease is present.

Figure 3: Coronary Angiography Image

The purpose of coronary angiography is to define coronary anatomy and the
degree of lumen obstruction of the coronary arteries and remains the standard for
providing physicians a vehicle to determine the location of potential coronary disease in a
patient [17]. Information obtained from the procedure includes identification of the
location, length and diameter of lumen, and contour of the arteries; the presence and
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severity of obstruction, characterization of the obstruction (i.e. presence of atheroma,
thrombus, dissection etc), and the nature of blood flow. There are three clinical situations
in which coronary angiography is used [18]: (1) to determine the presence and severity of
CAD in a setting in which the diagnosis is uncertain and CAD cannot be assessed by
noninvasive testing such as an echocardiogram or an electrocardiogram, (2) to assess the
appropriate form of intervention, such as revascularization or percutaneous surgical
intervention, (3) as a research tool for the assessment of treatment results and the
progression or regression of CAD [17].

Limitations of Coronary Angiography
Angiography has been the principal clinical tool for determining the severity of
luminal stenosis [15;17]; however, considerations regarding the accuracy and
reproducibility of coronary angiography are not to be overlooked.
The resolution of modern angiographic equipment, in the clinical setting, is
limited to approximately 0.2mm due to the effect of motion artifact, angle of imaging,
overlap of vessels, and image display resolution [19]. Other risks associated with this
invasive technique include: arterial puncture, iodinated contrast, and radiation. External
limitations include multiple staff members, costs, and the long observational period [17].
In 1992, the mean cost for cardiac catheterization for inpatients younger than 65 years
was $10,800 which may vary by state [20], but by the year 2000 the average total cost for
patients hospitalized for diagnostic cardiac catheterization increased to $16,838 [21].
In clinical practice, the degree of coronary arterial obstruction is expressed as a
percent of diameter stenosis. Percent stenosis is done by comparing the diameter of the
site of minimum lumen diameter segment to an adjacent segment that seems to be free of
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disease and is subject to visual assessment. When luminal narrowings are present on an
angiogram, further analysis almost always demonstrates severe obstruction; however, the
converse is not true. A normal angiogram does not exclude atherosclerosis, in fact, most
studies suggest that coronary angiography underestimates the severity of CAD [22;23];
there are several factors that contribute to this discrepancy.
First, coronary angiography illustrates coronary anatomy from a planar, twodimensional silhouette of the contrast-filled lumen (see Figure 3); however, lesions are
often very complex such that one angle of view may misrepresent the severity of
narrowing [24]. This can be especially difficult in the left main coronary artery where
two orthogonal angiograms may not accurately demonstrate the severity of lesions as
these orthogonal views are unobtainable because the stenosis may be obscured by
overlapping side branches [25]. Figure 4 provides an illustration of A) The direction of
the X-ray is above a vessel with plaque orthogonal to direction of scan; B) illustrates
what the X-ray image would be interpreted as, as if there were no obstructions to the
vessel (black color represents contrast agent); however C) illustrates what the image of
the vessel would look like if the scan direction was rotated 90 degrees, showing a clear
obstruction within the vessel (black being flow of contrast agent, and white being the
vessel obstruction).
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Figure 4: Illustration of Coronary Angiography Limitation: A) represents a vessel with plaque
orthogonal to the direction of the X-ray scan. B) Illustrates what the angiography image would look like
while X-ray scanning was orthogonal to plaque. (Black fill color represents contrast agent). C) Illustrates
what the angiography would represent if the scan direction were rotated 90 degrees (going into the paper),
indicated a clear obstruction within the vessel lumen.

Second, coronary “remodeling” may contribute to the inability of coronary
angiography to identify mild CAD [2;7;26-28]. Remodeling is a vascular enlargement of
plaque during the early stages of plaque accumulation, thereby concealing the
atherosclerosis from the angiogram. Once this atheroma becomes severe, the external part
of the vessel begins to enlarge, and atherosclerosis becomes evident. These unseen
lesions have been reported as a predisposing cause of acute coronary syndromes such as
myocardial infarction (MI) [29]. Figure 5 provides an illustration to depict how coronary
remodeling occurs within the vessel walls. In this case, during angiography, plaque build
up goes undetected as the contrast agent is able to travel through the vessel lumen
unobstructed.
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Figure 5: Coronary Remodeling: Coronary remodeling occurs when plaque builds up within the vessel
walls rather than within the lumen. Coronary angiography would not capture the disease as the contrast
agent would not be restricted from flowing through the lumen.

Third, coronary angiography only visualizes the lumen of the vessel and cannot
determine if the wall of the reference segment has CAD [22;30]. In the presence of
disease within the reference segment, percent stenosis will underestimate the true amount
of lumen narrowing [17;22;30].
These limitations have resulted in the development of new imaging methods to
help improve the assessment of CAD. Although these new techniques have not replaced
coronary angiography, they have provided additional valuable information that has
allowed further assessment of the severity and extent of lumen obstructions. Despite its
limitations, angiography still remains as one of the principal clinical tools in the
assessment of CAD.

Intravascular Ultrasound (IVUS)
Intravascular Ultrasound is an imaging technique that provides high-resolution,
real-time visualization of vessel morphology in vivo.

12
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structures has become imperative in the cardiovascular field, as cardiovascular diseases
(CVD) continue to take the lives of millions each year [1]. Despite the prevalence of
these diseases, IVUS technology provides imaging methods to properly diagnose and
intervene on patients who suffer from a CVD. Such methods include quantitative and
qualitative tools for acquiring accurate measurements of cross-sectional dimensions of
the arterial lumen [2;28], visualization and assessment of atherosclerotic plaque [2;31],
delineation of arterial wall morphology [2], and evaluation of the outcome of an
intravascular intervention [2;28]. Overall, IVUS provides a tomographic perspective of
lumen geometry and vessel wall structure that other diagnostic imaging techniques
cannot.
IVUS is an invasive catheter-based technique that is widely used to assess
atherosclerotic plaque [32]. At the tip of an IVUS catheter, a transducer emits an
ultrasound pulse and receives the reflected backscatter signal from the tissue where this
backscattered signal is then processed real-time into a 2D image. The image permits
accurate delineation of the vessel and lumen, dimensions, distribution and severity of
coronary plaque [33;34].
An imaging catheter is typically inserted percutaneously into the femoral artery
and directed by a guide-wire into the chambers and vessels of the heart (see Figure 6).
The imaging catheter differs in length and diameter based on the vessel being imaged. At
the proximal end of the catheter (end closest to physician), the catheter is connected to a
motor-drive unit that is used to spin the drive cable within the catheter sheath. This drive
cable is what spins the ultrasound transducer 360° and as the transducer is rotated by the
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drive cable at approximately 1800 rpm, the transducer generates and receives ultrasound
pulses to and from the coronary tissue.
Plaque

Guidewire

Drive Cable

Transceiver

Figure 6: IVUS Catheter in Artery: A mechanical IVUS catheter being pulled back with a coronary
vessel to expose vessel morphology. [Image provided by Boston Scientific]

The echoes, or received ultrasound pulses reflected by the tissue, are captured by the
transceiver and converted from a mechanical signal (or vibration) to an electrical signal
down the drive-cable. The electrical signal is then digitized and rendered onto a display,
providing the physician with a 360° cross-sectional view inside the coronary vessel (see
Figure 7).

Figure 7: IVUS image: Representation of a standard IVUS gray-scale image providing a 360° view of a
coronary vessel. [Image provided by Boston Scientific]
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Traditionally, coronary angiography has been used to provide a two-dimensional
silhouette of the lumen in coronary vessels to detect the degree and severity of stenosis.
Angiography heavily relies on the positioning of the system during imaging, since it only
provides a silhouette of the lumen, a physician may be incapable of properly diagnosing
he severity of atherosclerosis. Coronary IVUS is most often performed in conjunction
with coronary angiography. During an IVUS intervention, arteries as small in diameter as
1.5 mm can typically be visualized and typically the patient is given intravenous heparin
and intracoronary nitroglycerin which prevents blood coagulation within these small
coronary arteries. The procedure is typically performed by a cardiologist or interventional
cardiologist in a cardiac catheterization laboratory. IVUS imaging provides a
tomographic 360-degree sagittal scan of the vessel media (blood) to the vessel wall.
IVUS measurements of arterial dimensions (minimal and maximal diameters, crosssectional area, and plaque area) complement and enhance angiographic information.
When a mechanical pullback of the IVUS catheter is performed at a fixed rate, a threedimensional (3D) reconstruction of the artery can be obtained [35;36]. More details on
how IVUS works will be discussed in a later section.

Limitations of IVUS
As is the case with all technologies, there are limitations. One of the biggest
setbacks with IVUS technology is image interpretation. The technician studying the
images needs a solid understanding of the potential ultrasound artifacts. Generally,
artifacts are easily recognized, but in some cases artifacts may adversely affect the image
quality, and ultimately increase the difficulty of interpretation and reduce the accuracy of
the quantitative measurements [23;37].
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Artifacts are structures and features on an image that do not have a one-to-one
correlation to the object being scanned. Non-uniform rotational distortion (NURD), ringdown and geometric distortion are common artifacts that make image interpretation
difficult. NURD is only found in mechanical systems (explained later) and is caused by
uneven mechanical drag on the catheter drive shaft that results in cyclical oscillations in
rotational speed. Ring-down is a phenomenon that occurs immediately around the
catheter and results in bright circular areas in the image that can interfere with image
interpretation when the transducer is close to the arterial wall. Geometric distortion
results from imaging in an oblique plan, creating an elliptical, rather than circular, crosssectional image.
Another major limitation of IVUS is its low specificity for the diagnosis of a
thrombus. A thrombus, or blood clot, occurs when blood vessels are damaged and cause
platelets to adhere to the damaged endothelial cells; in most cases, the formation of a clot
is due to ruptured plaque. The formation of a thrombus on top of ruptured plaque is
considered to be a sign of an acute coronary syndrome and the use of IVUS to determine
the amount of clot contributing to a stenosis would greatly assist in clinical decision
making [23;38-40;40]. The limitation is due to the fact that a thrombus, under IVUS
image interpretation, looks similar to plaque tissue therefore making it difficult to
differentiate.

Optical Coherence Tomography (OCT)
OCT is similar to Intravascular Ultrasound (described later) but instead of
acoustic waves, a light source is emitted towards the sample [41]. The time delay
information and intensity of backscatter of light from the varying internal structures vary
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with optical properties. Because the speed of light is so fast, OCT uses a technique called
low-coherence interferometry, where light reflected back from the sample is measured by
correlating it with light that has travelled a known reference length. OCT uses near
infrared light, ~1300 nm, because light with a shorter wavelength is prone to a higher
degree of scattering and absorption, while light with a longer wavelength results in
undesirable absorption attenuation. With OCT, a spatial resolution of 4 to 16 µm is
achieved with a penetration depth of 2 to 3 mm. [42-44]

Limitations
One of the major limitations for OCT is that it requires a blood-free zone for
imaging that is accomplished by a saline flush or an occluding balloon. This is because
light is significantly absorbed and scattered by blood cells, which degrades the coherence
and image quality. Overall, it is a cumbersome procedure compared with other imaging
modalities [42-44]. Another limitation of OCT is that its depth range is limited to
approximately 3-4mm and depth penetration in tissue is limited to 1-3 mm, which limits
imaging beyond the internal elastic lamina [42-44]. Additionally, stent struts appear as
bright local reflections with shadowing sectors radially behind them, which gives the
tendency for OCT to underestimate the stent strut thickness in reference to
manufacturers’ specifications especially when blood is present [45]. Despite its
limitations, studies demonstrate the feasibility of cardiac OCT to visualize coronary
disease in patients [42-44].
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1.1.6 History of Intravascular Ultrasound
The start of ultrasound technology first began in 1880, where Paul and Jacques
Curie discovered that in some materials (notably crystals) an electric potential is
generated in response to mechanical stress (deformation); this technology was given the
name piezoelectricity. Similarly, the reverse was found true [46]. Consequently,
subsequent discoveries were made that led Sokolov to believe ultrasound could be used
for the detection of flaws in materials [47-49]. Later, in 1937, Sokolov was awarded a
patent for his ultrasound flaw-detection device [48]. It was not until 1942 an attempt was
reported on using ultrasound as a diagnostic tool. However, Meyer reports of earlier
applications of ultrasound for use in medical therapeutics [49].
Neurologist Dr. Karl Dussik of Vienna, Austria, was the first to attempt to use
ultrasound as a diagnostic tool in 1942 [49;50]. Dussik’s attempt was based on the
transmission method, where a sample (in this case the skull) was exposed to a beam of
ultrasonic rays by one transducer and recorded by another on the opposite side of the
sample. The changes in attenuation that traversed through the sample were recorded on
an oscilloscope. In 1952, Guttner et al. determined that the transmission method was of
no value due to the absorption and reflection of the bones within the cranium [50] and
another method was soon reported, known as the reflection method.
In 1949, Ludwig and Struthers attempted to use the reflection method to detect
gallstones and other foreign elements deep within the muscle of dogs [50]. The reflection
technique is where both the transmitter and receiver are located on the same side of the
sample under examination. Sound pulses are emitted for long intervals, where a fraction
of the sound is reflected by tissues with different densities – every kind of tissue has
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characteristic impedance that makes its reflection distinguishable. The reflected pulses, or
echoes, are recorded on an oscilloscope.
The development of ultrasound as a medical diagnostic and therapeutic tool in
cardiology began in the early 1950’s. Inge Edler, a cardiologist, and Carl Helmuth Hertz,
a physicist, collaborated together to see if ultrasound technology could be used to
examine the heart. Their first work entailed using a sonar device, or reflectoscope, to
record echoes from Hertz’s own heart [49].

However, as is the case with most

technologies, the rise of ultrasound in cardiology evolved from other applications of
ultrasound, as it was Edler’s job to evaluate cardiac patients prior to heart surgery [51].
Simultaneously, researchers such as Dr. Wild and Dr. Reid from the United States began
ultrasound studies on the human heart [47;52].
In 1966, 10 years after Wild and Reid first began studying the heart, Kossoff
described a catheter tip transducer of 2mm in diameter operating at 8 MHz for measuring
ventricular wall thickness [53]. A few years later, a group applied a 2.5 MHz cylindrical
element that radiated through a 360° arc [54]. At the same time, Stegall et al. introduced
two transducers mounted at the end of a catheter to determine the intra-aortic and intracarotid diameter [55]. However, it was Wells, in 1966, who first came up with a practical
design using an intravenous probe with mechanical rotation and a flexible shaft for
rotational real-time cross-sectional imaging [56]. But despite all these advancements in
intravascular ultrasound, there were many limitations that made IVUS imaging
impractical for clinical use such as not being able to conduct real-time analysis. Thus,
Bom et al set out to develop invasive real-time and cross-sectional ultrasonic imaging
using state-of-the-art technology. His group developed a 32-element circular phased array
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mounted on the tip of a catheter to record real-time intra-luminal images of ventricles in
animals; however, the catheter size and steerability provided serious limitations [57].
The simplest approach has been circumferential scanning with a single transducer
to provide cross-sectional imaging through the blood of the arterial wall under the
endothelial surface. The mechanical single-element design was investigated by many
groups and chosen over the electronic multi-element system as described by Bom. The
electronic multi-element phased array ultrasonic catheter allowed for a reduction in the
number of electrical wires, thus, a smaller size catheter with greater flexibility. However,
the main problem with the phased-array technology is that it was complicated and
expensive. Resolution and artifacts in the near field put limitations on the technology for
smaller diameter vessels and stenosis. These complications made the single-element
design much more attractive. The single-element is a design where the transducer was
mounted in the axis of the catheter where the ultrasound can be swept around in a plane
perpendicular to the catheter’s long axis by rotating the transducer (in a manner similar to
a lighthouse) to obtain a 360° display of the arterial cross-section. This technology was
great for imaging small arteries (i.e. coronary arteries) as the single transducer at high
frequencies (>20 MHz) had great attenuation with distance. [58]
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Chapter 2: Basic Principles of Ultrasound
In order to gain a greater understanding of the fundamentals for intravascular
ultrasound imaging, it is necessary to review some of the physical mechanisms that relate
to ultrasound and using ultrasound for coronary imaging. The following section provides
a survey of mechanical and acoustic principles for ultrasound imaging.

2.1 General
Sound can be described as a mechanical energy that propagates through a medium,
these are called – pressure waves. Ultrasound is defined as sound waves with frequencies
above the upper limit of human hearing of 20 kHz. Ultrasound imaging is based on the
reflection method (or pulse-echo method as described previously), where a short
ultrasound pulse is transmitted and received by the same source (transducer) that converts
electrical energy into acoustic energy, and vice versa. In the application of IVUS, the
transmitted ultrasound pulses travel through various coronary tissue and are scattered,
reflected and refracted at tissue boundaries. The scattered and reflected ultrasound waves
are called echoes; the receiver detects the acoustic vibrations and converts the vibrations
pulses back into electric signals for the IVUS system to interpret. Although there are
many diagnostic ultrasound applications, cardiology is one of the few fields that use high
frequency (>10 MHz) ultrasound as a diagnostic tool.
Before discussing the in-depth details of Intravascular Ultrasound, it is necessary to
discuss some of the fundamental concepts of ultrasound physics. This next section (Sec
2.2) is for novice readers and may be skipped by those who are familiar with the basic
concepts of ultrasound physics.
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2.2 Ultrasound Waves
Unlike most of the waves we encounter on a daily basis, ultrasound waves are
longitudinal mechanical waves that propagate at a frequency greater than 20 kHz –
beyond the range of human hearing. Mechanical waves are such that they need a medium
for propagation, unlike electromagnetic waves that travel at the speed of light and do not
need a medium to propagate.

Mechanical waves travel through deformable, elastic

mediums as the energy of the wave causes displacement of the medium particles. The
energy in the mechanical waves is transmitted through the motion of the particles, where
the medium itself does not move from one place to another. In other words, ultrasound is
the transmission of mechanical vibrations through a medium.
Mechanical waves are categorized as either longitudinal or transverse, which
correlates to the direction of the displacement of the individual particles of the medium.
All acoustic waves are longitudinal, where the particles in the medium move parallel to
the direction of the wave; conversely, transverse waves cause particles to displace
perpendicular to the direction of the wave. To visualize how an ultrasound wave
propagates, imagine the individual particles are connected to each other by springs. An
incident wave will cause the first particle to compress the spring between the first and
second particle. This compression energy is then transferred between particles two and
three and particles one and two undergo what is called rarefaction, this is a result of each
particle oscillating about its equilibrium point every time a wave passes [59].
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2.2.1 Frequency
Describing the temporal behavior of a sound wave is useful when modeling
ultrasound waves. The description of compression and rarefaction above will give us
something similar to a sine wave if we were to plot pressure versus time. Think of
acoustic pressure the same as atmospheric pressure. During compression, the acoustic
pressure is elevated above atmospheric pressure, and during rarefaction, the acoustic
pressure corresponds to where the pressure is lower than atmospheric pressure. The
resultant number of times per second either compression or rarefaction occurs at any
point is called frequency. The frequency of a sound wave is determined by the number of
oscillations per second made by the sound wave (e.g. sine wave).
The time it takes for the wave to complete a cycle is called the period. Period (T)
and frequency (f) are inversely related as shown [60-62]:

T=

1
f

1

2.2.2 Characteristics of Ultrasound
The propagation speed c of sound waves in a medium is determined by its bulk
modulus E and density ρ, where a more dense material has a greater the speed of sound
[60-62]:
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E

c=

2

ρ

The Intensity I of a sound wave, of the flow of energy through the unit area at a point is
related to the pressure amplitude p by [60-62]:

I=

p2
2 ρc

3

The physical property of a medium which determines the reflection of sound waves is its
acoustic impedance Z, the product of propagation velocity c and density ρ [60-62]:

Z = cρ

4

The wavelength λ, the distance between two consecutive points of equal pressure, is
related to the frequency f and the propagation speed c as follows [60-62]:

λ=

c
v

5

For a given medium, the higher the frequency the smaller the wavelength will be. The
propagation of a sound wave in tissue is influenced by physical effects of which the most
important are reflection, refraction, scattering, and absorption.
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2.2.3 Reflection and Refraction
As a sound wave passes from one medium to another with different acoustic
impedances, a part of the incident wave is reflected at the boundary and a part is
transmitted through to the second medium, generally with an altered direction of
propagation, better known as refraction.

The angle of the reflected wave is equal to the angle of the incident wave. The angle of
the refracted wave depends on the velocities of sound in the first and second media,
which is given by Snell’s law [60-62]:

sinθ1 c1
=
sinθ2 c2

6

The ultrasound speeds in biological soft tissues are very similar and there is only a little
deviation from the direction of the incident wave, which may be ignored.

The reflection coefficient R, the ratio for the reflected intensity IR and the incident
intensity II, is determined by the acoustic impedances Z1, Z2 of the two media, the
incident angle, and the angle of refraction [60-62]:

2
(
z2 cosθ1 − z1 cosθ2 )
R=
(z2 cosθ1 + z1 cosθ2 )2

25

7

Chapter 2: Basic Principles of Ultrasound
In the case where the incident wave is normal to the boundary, where θ1 = 0°, the
calculation of the reflection coefficient R is much simpler [60-62]:

2
(
z2 = z1 )
R=
(z2 + z1)2

8

The acoustic impedances of different soft tissues are slightly different, such that the
reflection coefficient is very small. At boundaries between soft tissue and bone or air, a
substantial part of the incident energy is reflected. Reflection and refraction describe the
phenomena at smooth boundaries with large dimensions compared to the wavelength. If
the boundary is not smooth, parts of the incident wave is reflected in different directions,
so in addition to the directed specular reflection (e.g. mirror) there is non-directional
reflection.

2.2.4 Scattering
If a sound wave strikes a boundary layer that is not smooth, where the dimensions
are comparable with or smaller than the wavelength, then part of the intensity of the wave
is scattered in all directions. The discontinuities at the boundary layer are local changes in
compressibility, density, or even both. The scattered parts of the wave resulting from the
randomly distributed scatters may superimpose. Thus, there may be an enhancement of
the intensity or the waves may cancel. Tissue is a grainy medium and because it is
composed of cells, the scattering of the grainy medium is the reason why the
homogenous regions of tissue show a “speckle” structure in ultrasound images.
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2.2.5 Absorption and Attenuation
Scattering and reflection of a sound wave propagating in tissue is not the main
reason for loss of energy; absorption is another primary factor in the loss of energy of
sound waves. The mechanical energy of the wave is transformed into heat which is
dissipated within the medium. The absorption depends on the medium and strongly
increases with frequencies in the frequency range used in medical diagnosis. The
exponential laws describe the amplitude A and the intensity I of the wave on the traveled
distance [60-62]:

A = Ao e − (γS )

9

I = I o e − ( 2 γS )

10

The absorption (attenuation) coefficient γ is in units dB/cm. Blood is known to have an
attenuation coefficient of 0.2 dB/cm at 1 MHz [58] – This value changes as the frequency
changes nonlinearly with frequency.

2.3 Ultrasound Transducer Properties
As mentioned previously, in general, a transducer refers to a device that converts
signals or energy from one form to another. Ultrasound transducers are used to convert
acoustic energy to electrical signals and electrical signals to acoustic energy; they are
used to detect and transmit ultrasound waves.
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Transducers used for medical ultrasound imaging employ the piezoelectric effect
to generate and detect sound waves (as described in Chapter 1). There are a number of
piezoelectric materials such as quartz that are used for diagnostic ultrasound, but lead
zirconate titanate (PZT) is the most common ceramic used in ultrasound imaging [61].
These materials must be polarized before they can transmit and receive sound waves
effectively. This is done by heating the material above 36.5° C, for PZT, and then
applying a high voltage across the material to align the crystals, which is also known as
polarization. The material is then cooled with the voltage still applied as this will allow
the material to maintain polarization, giving it the desired piezoelectric properties [61].
The speed of sound and thickness of a piezoelectric material determine its center
frequency. Transducers are also characterized by their transmit and receive sensitivity,
both as a function of frequency. The center frequency and bandwidth determine the pulse
length of the transducer. A transducer that is sensitive over a wide range (high
bandwidth) of frequencies can transmit short, broadband pulses. These properties are
essential is determining a transducers’ spatial resolution and will ultimately effect image
quality.

2.3.1 Solid-State vs. Mechanical Transducer Elements
A 360° cross-sectional tomographic image is produced with a variety of
technologies. Solid-state technology uses a circular multi-element phased-array of
transducer elements on the tip of a catheter (see Figure 8). The image is created by
sequentially firing the array of transducers, and simultaneously receiving echoes by
programming one set of transducers to transmit and another to receive.

28

Chapter 2: Basic Principles of Ultrasound
Mechanical technology uses a single element transducer located at the tip of a
catheter (see Figure 8). The transducer is rotated mechanically via a flexible drive shaft
connected to a drive motor. The transducer transmits and receives ultrasound signals at
approximately 1.5° increments to create the tomographic image. The transducer element
provides 256 vectors, or scan lines, for each image. The motor drive at the end of the
catheter facilitates uniform mechanical pullback of the transducer within a protective
sheath. The experiments performed in this thesis used the single element mechanical
technology just described.

Figure 8: Multi-element and single element technologies [Image provided by Boston Scientific]

2.3.2 Resolution
Due to its ability to provide detailed in vivo images of coronary vessels, IVUS has
assumed the role in the diagnosis and treatment of coronary artery diseases. As IVUS
technology progressed, a wide array of systems, catheters, and transducers have been
developed to provide enhanced image quality. IVUS image quality is especially
important in that detecting the small differences may play an important role in identifying
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vulnerable plaque in a vessel or determining the outcome of specific therapy. There are
many key players in IVUS that enhance the quality of the system overall; these basic
principles are what drive the success of an intravascular ultrasound system, and the main
component being the transducer as it drives the resolution capability of the entire system.

Spatial Resolution
Optimizing resolution is one of the most important elements in an ultrasound
system; the better the resolution, the better the image quality (i.e. clarity). Resolution is
the minimum distance two targets can be distinguished on a display. There are two types
of resolutions important to ultrasound imaging: axial and lateral resolution, both of
which are directly related to the transmission frequency and transducer used and are key
elements in the image quality for IVUS.

Axial Resolution
Axial resolution is the resolution along the axis of the ultrasound beam, and is
determined by the pulse length (determined by transducer frequency and bandwidth) - the
shorter the pulse length (i.e. higher the frequency), the greater the resolution and is
described by the following:

Axial Resolution = spatial pulse length (SPL) / 2
Where SPL = λ x no. of cycles
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The axial resolution of a transducer is generally better than its lateral resolution,
where the axial resolution for a 20 MHz transducer is 200 microns and approximately
100 microns for a 40 MHz transducer [58]. Figure 9 provides a visual diagram to help
better understand this characteristic. Axial resolution is dependent on the pulse length.
Because the ultrasound pulse is small enough in this example, the transducer will pick up
two reflections. As the scattering elements approach each other, the pulse becomes longer
in comparison, thus only one reflection will be seen by the system.

Figure 9: Axial Resolution Representation The black box represents the transceiver element rotating
360° within the catheter. The scattering elements are the black, small and round dots. A) Represents the
ultrasound signal (US) being emitted from the transceiver traveling towards the scattering element. The US
spatial pulse length is represented byt eh magnitude or length of the black arrows. B) As the US hits the
first scatterer, a portion of the US is reflected back to the transceiver while another portion is transmitted
through the element towards the next element. C) The first reflected US hits the transceiver while the
second reflected US begins traveling towards the transceiver. D) The final reflection from the second
scatterer reaches the transceiver at a time after the first, enabling the transceiver to differentiate between
both reflections. Axial resolution is dependent on the pulse length. Because the ultrasound pulse is small
enough in this example, the transducer will pick up two reflections. As the scattering elements approach
each other, the pulse becomes longer in comparison, thus only one reflection will be seen by the system.
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Lateral Resolution
Lateral resolution can be described as the resolution perpendicular to the beam
axis and is directly related to the beam cross-section (See Figure 10). Said differently, it
is the ability to distinguish adjacent targets perpendicular to the ultrasound beam. Lateral
resolution is determined by the geometry of the transducer (the diameter) and
transmission frequency. Basically, two objects side by side (see Figure 10) cannot be
distinguished if they are separated by less than the beam width of the transceiver. The
determinants of beam width are transducer frequency where beam width increases with
lower frequency transducers and vice verse. We already know that resolution increases
with frequency, however, attenuation of the ultrasound wave increases as the frequency
increases, and as a result, the penetration depth is limited. This is due to the US wave
becoming smaller in wavelength, making it unable to penetrate elements that are bigger
than the wavelength itself. Consequently, non-invasive ultrasound imaging is performed
at 1-5 MHz in order to optimize the penetration depth [63]. High frequency ultrasound
applications (>10 MHz) have penetration depths of <1.5cm, but have higher resolutions
(<200 µm). Typical 40 MHz IVUS transducers provide approximately 0.5 mm of lateral
resolution [58].
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Figure 10: Lateral Resolution Diagram This illustration shows that the beam width, or diameter of the
transducer, determines the lateral resolution. The smaller the beam width, the more capable a ultrasound
system can differentiate between two elements. Also, due to beam spreading, once the scattering element is
beyond the focal point, lateral resolution begins to worsen as shown. This can only be improved by
decreasing the size of the transducer itself.

2.4 Intravascular Ultrasound System
A typical IVUS system consists of six main components as shown in the
schematic below (see Figure 11): Catheter, motor drive unit, transmitter, receiver, signal
processing module, and the display. The ultrasound transducer sits at the tip of the
catheter. As described previously, the motor drive unit rotates the drive cable that the
transducer sits on at 1800 rpm.

Figure 11: Basic IVUS System Block Diagram
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The transmitter generates short voltage pulses that are applied to the piezoelectric
crystal in the transducer. The amplitude and frequency of the pulse can be adjusted with
the system where a typical excitation pulse ranges from 50 – 100 V, with frequencies
ranging from 10 – 40 MHz.
The receiver amplifies the small voltage signals that are returning echoes from the
tissue striking the transducer. Because ultrasound is attenuated as it travels through tissue,
and because some scaterrer elements are further away than others, a time-dependent
amplification, generally called time-gain compensation (TGC), is used to compensate for
the attenuation loss and time delay. Attenuation occurs as an US signal penetrates
scatterers (i.e. blood and tissue) causing some of the US energy to be reflected in
different directions and never being detected by the transceiver. Filters and a master gain
control are also used for noise reduction and global amplification if needed.
Because the human eye can only distinguish about 200 different gray levels, the
received echo signal is compressed by an adjustable logarithmic amplifier to avoid a loss
of information when transformed into a video image – the dynamic range of the received
signal is about 50 dB [58;61]. At the same time, the high frequency echo signal is
demodulated to obtain an enveloped signal, or an intensity signal. Once this occurs, the
intensity signal is then scan converted. Scan conversion is necessary because scanning of
the vessel cross-section creates a series of intensity scan lines that have to be transformed
for a 360° geometrical display. Closer to the transducer these scan lines may overlap,
therefore, during scan conversion the intensity of pixels close to the transducer is
calculated by averaging over several scan lines. Averaging over several images may
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reduce image noise and may be used to increase image quality. Finally, the signal
processed intensity signal is displayed on the video monitor.

2.5 Physical Properties of Tissue Relevant to IVUS
Although IVUS has proven to be a highly accurate imaging modality, widely used
as a complimentary diagnostic tool to angiography, much of the research today is focused
on methods of continuing to improve upon resolution and image quality. The focus of
this study was to determine the feasibility of improving upon the blood-tissue boundary
by using a multi-frequency enhancement method. Blood has shown to be frequency
dependent, whereas tissue has not - perhaps this is due to the increase in the size of the
scattering element [64]. Thus, understanding the physical and acoustic properties of both
the blood and vascular tissue are of importance. The following sections will outline the
results of previous studies on the physical and acoustic properties for both blood and
arterial tissue.

2.5.1 Properties of Arterial Tissue

Mechanical Properties
There are three layers of an artery: the intima, media, and adventitia. The intima
consists of the endothelium, which is a single-cell layer of connective tissue that
encounters the blood within the artery. The media consists of smooth muscle layers
composed of elastin and collagen fibers. The adventitia is composed of mostly collagen
fibers. Thus, arteries are multi-layered anisotropic structures that are pre-stressed
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longitudinally and circumferentially based on the orientation of the smooth muscle in
each layer. Additional mechanical and acoustic properties relevant to this study are
discussed further in the following sections.

Acoustic Properties
As with any media, ultrasound propagation through the artery results in
attenuation and distortion of the ultrasound beam by refraction and diffraction. According
to Duck [65], the speed of sound for whole arteries was found to be 1616 cm/s. This was
verified by Saijo et al who reported an average velocity of 1619 ± 42 m/s [66]. Due to the
physics of ultrasound, as the media in which the ultrasound is propagating in becomes
more dense, the beam will propagate faster through the media. This incident was
observed by Rooney et al as they report a velocity as high as 2000 m/s in diseases arteries
with high level of collagen and cholesterol [67]. Attenuation in the arteries has been
reported by [67-69]. The average attenuation for all three layers of the artery is 11 ± 4
db/cm/MHz, higher in calcified regions, and lower in lipid regions.
Lockwood reported on the acoustic backscatter derived from arterial tissues [70],
but these were not within the coronary vessels. Lockwood and other authors report that
the acoustic backscatter measurements in the arteries have demonstrated higher
backscatter in regions of calcification and fibrous plague compared to healthy arteries.
However, none of which conclude that arterial tissue is frequency dependent.
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2.5.2 Properties of Blood
Intravascular ultrasound has become a valuable diagnostic tool in interventional
cardiology, providing physicians with detailed, high quality, cross-sectional images of
vessels. However, resolution and image quality are the primary focus of research. As
described previously, resolution enhances the discrimination between various biological
tissues. Therefore, as the resolution increases, the image quality increases where the
resolution of an imaging system greatly depends on the center frequency of the
transducer. As the frequency increases, the axial resolution increases because it is
determined by the length of the ultrasound pulse, which means, the shorter the pulse
length, the greater the axial resolution. However, as the frequency increases, studies have
noticed that there is a strong blood backscatter (echo) signal that makes blood appear like
tissue, which may cause difficulties in the discrimination between the lumen and arterial
wall boundaries [64;70;71]. Additionally, there are many other factors that may affect the
echogenicity, or the tendency of tissue to reflect ultrasound, of blood backscatter.
Researchers have reported that the hemodynamic and hematological factors such as
hematocrit, protein concentrations, and blood flow dynamics [72;72-75] affect the
echogenicity of blood; thus, the properties of scattering in blood should be well
understood. In the following section, blood as a medium in ultrasound will be given.

Physical Properties
Blood is composed of liquid called plasma where erythrocytes (red blood cells),
leukocytes (white blood cells), and platelets are suspended. Erythrocytes are elastic,
nonnucleated bioconcave disks with an average diameter of 7µm and a thickness of 2µm
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[76;77]. The number of red blood cells is significantly larger than that of white cells and
the volume of a red cell is much larger than that of a platelet [77]. Thus, scattering of
ultrasound by blood is presumably due to red blood cells [76].

Mechanical Properties
Blood is non-Newtonian and is shear-thinning, such that the viscosity of blood
decreases with an increase in shear rate [77]. The shear thinning properties of blood is
known to be a result of changes in the aggregation and deformation behavior of the red
cells [78]. At low shear rates, the red cells form rouleaux, in which the red cells join base
to base, creating an interlocking structure so that the blood resembles a solid – essentially
increasing the scatterer size and ultimately the echo intensity. An increase in shear rate
breaks down the “bridging” between cells and reduces the rouleaux length, thus the
number of individual blood cells increase. A study has shown that for shear rate in the
range 0 to 1 s-1, aggregation dominates the viscous behavior, whereas in the range 1 to
100 s-1, deformation is the dominant factor [79].

Acoustic Properties
The backscatter signal from blood arises from the scattering elements that are
individual red blood cells and red cell aggregates, called rouleaux. For scatterers small
with respect to wavelength, there is Rayleigh scattering with dependence on transmit
frequency, f, of f4, whereas scatterers large with respect to the wavelength show no
dependence on transmit frequency [80]. A frequency dependence of f3.5 in whole human
blood at a shear rate of 32 s-1 at 40 to 60 MHz was found by Foster [64]. A lower
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frequency dependence occurs where aggregation is expected because of the larger size of
the scattering particles [64;74]. Other factors such as red cell volume [81], transmit
frequency [82], shear rate [74;83;84], hematocrit [84-86], fibrinogen concentration
[82;87;88], turbulence [85], angle [89]and cycle length all influence the backscatter
signal from blood. Fontaine et al. concluded that the main determinant in backscatter
power is red cell aggregation [72]. Understanding these properties will provide a better
understanding when trying to differentiate between red blood cells and arterial tissue
during IVUS imaging.

2.5.3 Blood versus Arterial Tissue
The purpose of this study is to determine the feasibility of using a multi-frequency
processing method to differentiate between blood and arterial wall, which will ultimately
enable us to delineate the blood-tissue boundary and assess the degree of lumen reduction
for atherosclerosis.
First, in 1991, Lockwood reported that blood, at high frequencies (25-65Mhz)
“was found to produce scattering that was within an order of magnitude of what was
measured in some vascular tissues” [70]. Then, in 1994, Foster reported that at low shear
rates and high frequency, the backscatter power from blood was comparable with the
backscatter from the tissue media [64]. The force to improve upon image quality will lead
to higher frequency imaging, and as Foster and Lockwood found, the frequency
dependency of blood could increase the contrast on IVUS images where the
discrimination of the blood-wall lumen would not be as easy to delineate compared with
lower frequencies. The following experiment was designed in such a way as to determine
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the feasibility of a method to increase the contrast between the blood-wall lumen
boundary that is substantially grounded on the premises of prior studies.
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Chapter 3: Multi-Frequency Processing for Lumen
Enhancement
3.1 Overview
The use of high frequency ultrasound is the key to obtaining higher resolution
IVUS images. As stated previously, the greater the transducers’ center frequency, the
greater the image resolution. Consequently, increasing the transducer center frequency
beyond that of the standard 40 MHz may introduce some challenges from stronger
scattering intensities from blood as reported in the previous section by Foster [64] and
Lockwood [70]. This high level of blood scattering may obscure the arterial lumen and
make image interpretation difficult for physicians [90]. However, frequency dependency
by blood may provide the potential to distinguish blood from tissue by means of multifrequency processing techniques. In order to obtain a good blood-tissue contrast with
sufficient signal-to-noise ratio, a system with a wider bandwidth is desirable. The
proposed method is based on the Multi-Frequency Signal Ratio (MFSR) of the received
signal power between the high (60 MHz) and low (25 MHz) frequency ranges of a novel
wideband high-frequency coronary catheter.

3.2 Materials and Methodology
An experimental system, referred to as a phantom, was designed to allow
simulated arterial ultrasound images to be collected and measurements to be made.
Phantoms have been used in previous research to help interpret clinical scanning, validate
measurements used in clinical practice and clinical research, and help characterize
imaging systems in the development of new ultrasound techniques. The ultrasound
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measurements taken using phantoms should be similar to scanning in patients. Imaging
and measurement in vivo are critically dependent on the physical properties of the
different tissues through which the ultrasound beam passes. Thus, it is critical that the
relevant physical properties of the phantom be similar to human tissues.
For this study, a flow phantom was designed to mimic the flow of blood through a
coronary vessel of 4mm in diameter under steady flow conditions only. Due to the
complexity and numerous effects associated with non-steady flow conditions, it was
determined that a steady flow be used in this experiment as the main goal is to provide
feasibility of a signal processing technique.

3.2.1 Flow Phantom Setup
Figure 12 shows a blood flow diagram of the experimental setup used for the invitro study. The setup consists of a mechanical pump (Masterflex, Barrington, IL; Model
No. 7520-40) to circulate the media throughout the model at a pump speed of 6 – 600
rpm.

The system flow rate is monitored using a flow meter (Accucal®, Barnant

Company; Model GF-6540-1230) that comes with a flow rate analysis software (Barnant
Company; Model GF-4000) to correlate the flow meter scale reading (0-100) to an actual
rate that depends on flow factors such as media density, viscosity, and temperature. Due
to material and monetary constraints of this study a standard vascular phantom (ATS
Laboratories, Bridgeport, CT; Model 524) was used to mimic coronary arterial tissue.
The phantom consists of 4 lumen channels, 14 cm in length, with diameters of 2, 4, 6, and
8 mm. For the purpose of this study, the center region of the 4 mm diameter channel was
used because the 2mm channel does not provide a large enough imaging field for data
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collection, while the 6 and 8 mm channels are not likely to be seen in clinical practice –
most coronary arteries range between 2 – 4 mm [60]. The phantom is composed of a
urethane rubber with a speed of sound equal to 1460 m/s with an attenuation coefficient
of 0.5 dB/cm/MHz. Geometrical considerations of the vascular phantom will be
discussed in the next section. This phantom was chosen for this study because it produced
characteristics that closely reflect what would be seen in clinical practice.

Figure 12: Blood Flow Model Diagram

The actual setup is shown in Figure 13 and consists of two loops (see Figure 12):
the main loop is used for porcine blood flow and imaging while the secondary loop is
used to determine the flow velocity using Blood-Mimicking Fluid (BMF). Two loops
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were used in this setup mainly because the color of the porcine blood would make it
difficult to read the flowmeter scale, so the BMF which has more of a transparent
characteristic was pumped in the secondary loop.
The physical and acoustic properties of the BMF and human blood are compared
in Table 1 below. The blood mimicking fluid consists of an Orgasol™ 5 µm nylon
scattering particle and is described in further detail in previous work [91]. A sample of
porcine whole blood was collected, with EDTA solution (25% HMT) as an anticoagulant,
from a local animal laboratory. Within the main loop, the mechanical pump was used to
control the flow speed within the system. Downstream from the pump is the vascular
phantom that consists of a 4mm diameter channel made of rubber urethane. Due to its
acoustic properties, the vascular phantom is used to mimic a coronary vessel in the heart
and it is the location of the imaging window – the point at which the imaging catheter
rests and performs imaging. A hot plate is used to control the temperature of the porcine
blood at 37.5° C ± 0.5 by providing a feedback loop to the temperature controller. At the
same time, a magnetic stir bar is placed within the blood reservoir to prevent aggregation
within the flow loop. This temperature was chosen as it closely mimics the core
temperature of human blood. As shown in Figure 13, the Masterflex tubes connecting
each component together were tightly wrapped in aluminum foil. The purpose of this was
to minimize the thermal loss experienced by the blood as it traveled through the system.
At the same time, a heater pump (outside of view) was used to pump heated water over
the top of the vascular phantom where most of the heat seemed to escape. A simple
experiment showed that this method reduced the thermal effects experienced on the
system by approximately 2° C.
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1
6

2
5
3

4

Figure 13: Blood flow model setup. (1) Masterflex mechanical pump, (2) Blood-Mimicking Fluid, (3)
Vascular Phantom, (4) Hot Plate, (5) Porcine blood reservoir, (6) Flowmeter. Not shown is a water pump
that was used to pump warm water over the surface of the vascular phantom (3) in order to optimize
thermal losses within the system, keeping the blood at a nominal temperature of 37.5° C.

Table 1: Physical and acoustic properties of blood-mimicking fluid compared to whole human blood.

Properties
Scatterer
Scatterer size (µm)
Hematocrit (% volume)
Density (kg m-3)
Viscosity (mPa s)
Velocity (m s-1)
Attenuation (dB/cm/MHz)

Human
(37°C)

Blood Blood-Mimicking
Fluid
Orgasol™
(nylon
Red blood cells
particles)
7
5
45
<5
1053
1037 ± 2
3
4.1 ± 0.1
1583
1548 ± 5
0.15
0.05 ± 0.01
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3.2.2 Vascular Phantom
For this study, the imaging catheter was inserted into the 4mm diameter channel
of the vascular phantom, approximately 7 cm into the lumen to ensure the entrance length
of the fluid media had reached a full velocity profile. In long and straight pipes, we know
the flow is axial and axisymmetric [92], and given that the channel is rigid, the velocity
profile can be described analytically. In a straight channel, the velocity profile will
change with time and distance from the entrance of the tube, remaining unchanged
beyond a certain distance called the inlet length. For steady flow, the velocity profile
beyond the inlet length is parabolic (see Figure 14). Generally, the insonation region is
the region beyond the inlet length where the velocity profiles are stable with distance (i.e.
where imaging occurs). For this study, the insonation region was within the 7 cm inlet
length designed for the flow phantom. The formula for the inlet length is given by
[92;93]:

L = 0.04dRe

11

where L is the entrance length, d is the diameter of the tube. In order to maintain laminar
flow, the Reynold’s number must be less than the critical value of 2000 as given by [92]:
Re =

Vdρ

12

µ

where V is mean velocity, ρ is density, µ is dynamic viscosity, and Re is the Reynolds
number. Knowing the mean velocity and diameter of the vessel, we can determine the
Reynold’s number, which is an indication of whether or not the velocity profile will be
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stable. Given the physical properties of blood shown in Table 1 previously, the
Reynold’s number calculated from equation 12, and outlined in

Table 2, is valid for steady flow given the range of mean flow velocities. Thus, with a
max Re of 421, a minimum entrance length of 6.73 cm is needed for a time-varying
velocity profile to become fully developed; for this study, the designed inlet length
satisfies the theoretical inlet length.

Figure 14: Velocity Profile Diagram

Table 2: Reynold's number and stability at varying mean flow velocities.

Mean Flow Velocity
(cm/s)
0
5
10
15

Reynolds Number
(Re)
0
70
140
210

Flow Stability
Laminar
Laminar
Laminar
Laminar
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20
25
30

280
351
421

Laminar
Laminar
Laminar

3.2.3 Intravascular Ultrasound Imaging System
The iLab™ ultrasound imaging system was provided by Boston Scientific
(Natick, MA, USA). The imaging system consists of two PC’s and a motor drive unit.
The acquisition PC is where the raw RF data is filtered, enveloped, and other digital
signal processing methods are performed. The data was then transferred from the
acquisition PC to an imaging PC, where the data is scan converted into a two dimensional
grey-scale image. The motor drive unit (MDU) is another peripheral component to the
iLab™ system and is the interface between the coronary imaging catheter and the iLab™
system. The coronary catheter had a center frequency of 40MHz and a bandwidth of
80%. The MDU drives the cable shaft at 1800 rpm and sends the transmission pulse to
the transducer element that is housed at the distal tip of the catheter.

3.2.4 Coronary Catheter
A coronary catheter with a novel transducer was used for this study in order to
take complete advantage of capturing the high and low frequencies. Typical coronary
catheter transducers have a center frequency of 40 MHz with a 40% bandwidth (BW). In
other words, most of the used signal power, i.e. – 6dB fractional BW, from the transducer
will range from 26 to 56 MHz. Using a catheter with such low BW will not allow us to
capture data that can be differentiated between the high and low frequency (as will be
explained later) – in this case, the high frequency would be 26 MHz and the low would
be 56 MHz.
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A novel transducer developed by Jian Yuan et al. [94] provided 80% BW. Figure
15 provides a graphical representation of the difference in frequency response for a
typical 40% BW coronary catheter and a high BW catheter at 80% BW, both with the
same center frequency. Figure 16 now compares the frequency responses of the coronary
transducers to a typical frequency response of blood and tissue. We can see that for a
typical 40% BW catheter, the responses for blood and tissue are outside the boundaries as
to where the catheter can perform. On the other hand, the blood and tissue responses
seem to be enveloped by the frequency response of the 80% BW catheter.

Figure 15: Frequency Response of High Bandwidth Transducer: The graph on the left represents the
frequency response for a typical 40 MHz 10% BW coronary catheter transducer. The graph on the right
depicts the frequency response of a higher bandwidth transducer, approximately 80%. [Image provided by
Boston Scientific]
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Figure 16 Blood and Tissue Frequency Response: The red dotted line portrays a typical blood frequency
response while the green dashed line indicates the frequency response for normal arterial tissue. These
tissues are prominent at different frequencies, which is the foundation of this study.

This novel, high bandwidth, coronary catheter transducer enables this study to
collect data at a low and high enough frequency to enable us to study the potential
differences of backscatter response at those frequencies to determine frequency
dependency.

3.2.5 Data Acquisition and Analysis
Two 12-bit, Agilent Technologies PCI analog-to-digital converter boards (Acqiris
DP310, Monroe, NY), along with Matlab® software, were used to collect original RF data
for post-processing analysis. The RF data was sampled at a 400 MHz sampling frequency
and divided into a 2048x256 matrix, where one matrix represents a single IVUS frame.
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The number of frames collected was not a factor for data analyses since imaging was
performed at a stationary position where all frames essentially represent the same RF
data. In order to determine the power ratio at each flow velocity, a fourth order
Butterworth band-pass digital filter was used to suppress everything but the highfrequency (60MHz 30% BW) and low-frequency (25MHz 80% BW) data from the
original RF data set. The filtered data was then squared and averaged to determine the
mean power signal.
A region of interest (ROI) was selected within two to three millimeters from the
center of the lumen to represent blood data within the vessel under study (see ROI#1 in
Figure 17). ROI #2 represents data that reflects a region of the vessel comprised of tissue
only. Each ROI contained 300 total samples of data, where 10 vectors of 30 samples per
vector were collected.
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ROI #1

ROI #2

Figure 17: Region of Interest (ROI): ROI#1 represents blood data collected within the vessel lumen.
ROI#2 represents tissue data collected of the same vessel. Each ROI contains 10 vectors or columns of
data, and each vector comprises of 30 samples for a total of 300 samples per ROI.

High-frequency data (60MHz 30% BW) and low-frequency data (25MHz 80%
BW) were collected for each ROI. Each vector was averaged and then the average of all
the vectors within a ROI was calculated. For high-frequency data A60 represents the
average power for a particular ROI. A25 represents the low-frequency average power for a
particular ROI. Thus, in order to determine the Multi-Frequency Signal Ratio, or MFSR,
the following equation was derived:

MFSR =

A60
A25

13

The MFSR, where the high-frequency data (average power signal) is divided by the lowfrequency average power signal, was calculated for each ROI.
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The MFSR is what tells us if there is a correlation between the high-frequency
(HF) filtered data and the low-frequency (LF) filtered data. The greater this ratio, the less
correlation there is, meaning the HF and LF data do not match. In other words, the
greater the MFSR value, the greater the sample is frequency dependent. If the HF and LF
data do match, we would see a low MFSR value, indicating that biological tissue is not
affected by frequency (frequency independent) and will be difficult to differentiate
biological tissues using different frequencies. Figure 18 provides an overview of the
post-analysis process.
Before continuing on, it is important to note why the 60 MHz and 25 MHz
frequencies were used for this experiment. As mentioned previously, the center frequency
of the imaging catheter was 40MHz, but the important part is its ability to transmit with
80% bandwidth. Essentially the catheter can transmit signals from 8MHz to 72 MHz.
Since the transmitted power is max at the center frequency (40MHz) and derates at all
other frequencies, we wanted to capture the highest and lowest frequencies that can still
transmit a lot of power. At -3dB, 50% of the max power is being generated, so any
frequencies within the -3dB range will suffice. The 25 and 60MHz frequencies lie within
this range and provide a broad enough spectrum for testing the MFSR theory.
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60 MHz Band-Pass Filter

Power Signal

Average Signal

High-Frequency Data set
(2048x256)

High-Frequency Data set
(2048x256)

High-Frequency Data set
(2048x256)

25 MHz Band-Pass Filter

Power Signal

Average Signal

Low-Frequency Data set
(2048x256)

Low-Frequency Data set
(2048x256)

Low-Frequency Data set
(2048x256)

A/D
400 MHz Sampling
Frequency

Original Digitized RF Data
set (2048x256)

Figure 18: Multi-frequency post-processing analysis flowchart. The final step in this post-analysis process is to take the average of the averaged signal shown
above, which is not shown. This final numerical value provides us with A60 and A25. Taking the ratio of A60 over A25, we can determine the MFSR and
ultimately understand whether or not that particular sample is frequency dependent.

54

Chapter 3: Multi-Frequency Lumen Enhancement

3.3 Results and Discussion

3.3.1 In-Vitro Study
The MFSR results for the porcine blood at various flow velocities and for the
tissue mimicking wall are summarized in Table 3. Examining the data for mean flow
velocity for blood gave us an MFSR of 2.77 (43.73 / 15.76 = 2.77), but the MFSR for
tissue is 0.28 (17.44 / 61.18 = 0.28). As mentioned previously, the higher the MFSR, the
more dependent the data is on frequency. The MFSR values of blood regions are
consistently higher than those measured from the wall, where blood has an average
MFSR value 8x greater than that of tissue. What this means is that the intensity of the
backscattering level for blood is much greater than tissue at higher frequencies, making it
easy for an algorithm to detect which RF signals are blood and tissue. One interesting
observation was the MFSR value was higher at the low flow velocities then at all other
velocities, which may provide a unique advantage in detecting blood speckle under
stagnant flow. The underlying physics of this phenomenon still need to be understood but
can mostly be attributed to the rouleaux phenomenon – as described by previous studies
cited in this chapter. This rouleaux phenomenon causes the blood cells to clump or stick
together, essentially becoming denser and more echogenetic, or better said, the blood
cells backscatter intensity will increase because the cell size increases. This method is
advantageous over current blood detection methods used clinically in that those methods
use a time-based correlation technique which does not work well in low flow
environments as these methods expect blood to be rapidly changing continuously but is
not always be the case. A more visual representation of Table 3 can be found in Figure
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19 – the MFSR values are plotted against velocity, all other data from Table 3 was
omitted from this plot.
The results in Table 3 give us insight into the ability to use the MFSR technique
to clearly detect blood flow within a vessel and better delineate the lumen boundary
between blood and tissue. As mentioned previously, this is advantageous because it
enables physicians to better determine the lumen diameter of a diseased vessel and
provide the right therapy.

Table 3: MFSR results for whole porcine blood (37.5°C) and a tissue-mimicking media

Porcine Blood
(25% Hematocrit)
Mean
Flow
Velocity
(cm/s)
0
5
10
15
20
25
30

Tissue-Mimicking Wall (TMW)

HF
Signal
Power

LF
Signal MFSR
Power

HF
LF
Signal Signal
Power Power

MFSR

71.12
43.73
35.13
33.54
33.40
34.12
37.04

27.36
15.76
14.75
14.75
14.9
15.29
15.91

16.25
17.44
17.75
17.54
15.61
19.09
18.52

0.29
0.28
0.31
0.27
0.32
0.29
0.27

2.59
2.77
2.38
2.27
2.23
2.23
2.32

54.99
61.18
57.07
63.39
48.48
65.40
67.05

A quantitative analysis is shown in Figure 20 as it provides a plot of the
backscatter intensity (amplitude) in the blood regions at varying flow rates. We can see
that MFSR for blood is greater at all flow velocities at higher frequencies (60 MHz)
compared to the lower frequency (25 MHz). It is important to note that there is a jump in
intensity with blood at the stagnant flow region (0 cm/s) and can be associated with the
lack of movement in the vessel and increased cell size of blood (due to rouleaux). When
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the vessel is not moving the noise in the system is minimized and it will be easier for the
receiver to pick up all signals from the cells (due to less interference), thus increasing the
intensity of the received signal. Although blood has increased amplitudes at stagnant
flow, we can attribute some of it to a stable, non-moving system rather than attributing it
to this MFSR technique.
ROI MFSR Measurement
3

MFSR Value

2.5
2
Blood ROIs

1.5

Wall ROIs

1
0.5
0
0

5

10

15

20

25

30

35

Flow Velocity (cm/s)

Figure 19: Mean Multi-Frequency Signal Ratio values measured in the blood-filled and wall regions
with varying flow rates. The values are consistently higher for the blood than the tissue of the entire range
of the flow rates.
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Figure 20: Mean signal amplitudes with the 60 and 25 MHz band-pass filters measured in the bloodfilled ROI.

Appendix A provides an understanding of IVUS images and portrays the lumen
enhancement technique implemented using the data captured from this in vitro study. The
images portray the blood and tissue becoming more apparent at the frequencies used for
this study and indicates visually that this method can be verified qualitatively. The left
image is the conventional 40 MHz (40% bandwidth) IVUS image within the blood flow
phantom as used in the study. The 40 MHz image shown has not been post-processed in
any way. The middle and right images have been multi-frequency processed as described
in the Data Acquisition section above.
According to the studies presented earlier on the properties of blood and tissue,
we would expect to see the tissue to be the most prominent scattering element when
filtered at lower frequencies, and blood to be the most prominent scatterer at higher
frequencies. The 25 MHz image in the middle clearly highlights the tissue mimicking
media within the vascular phantom; the porcine blood is indistinguishable. However, the
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60 MHz filtered image clearly distinguished the porcine blood in the image, and this time
the tissue has been attenuated – suggesting tissue is frequency dependent at lower
frequencies and blood is frequency dependent at higher frequencies. This comparison
qualitatively indicates that there is a clear distinction between the blood and tissue when
using the multi-frequency processing technique suggested in this paper.

3.3.1 In-Vivo Study
Figure 21: In vivo coronary image showing visual enhancement of a thrombus
(Arrow). A) 40-MHz high resolution IVUS image. B) MFSR image obtained but the
multi-frequency processing. C) Color-coded blood speckles to enhance the arterial
lumen. The thrombus is difficult to recognize due to its echo intensities similar to
blood, particularly, on the still frame.Figure 21 shows the lumen enhancement
obtained from an in vivo animal study. This example demonstrates the ability of this
method to produce a clean delineation between the arterial wall and blood.
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A

C
B

Figure 21: In vivo coronary image showing visual enhancement of a thrombus (Arrow). A) 40-MHz
high resolution IVUS image. B) MFSR image obtained but the multi-frequency processing. C) Color-coded
blood speckles to enhance the arterial lumen. The thrombus is difficult to recognize due to its echo
intensities similar to blood, particularly, on the still frame.

This study helps qualitatively validate this multi-frequency technique.
Furthermore, this study helps demonstrate the MFSR technique to produce a clear
delineation of the thrombus, which is otherwise difficult to recognize because it was
surrounded by blood speckles having similar intensities.

3.4 Conclusion
Strong scattering from blood due to the use of high ultrasonic frequencies has
been a constant challenge for improving IVUS image quality. Most of the previously
reported IVUS lumen enhancement techniques have taken advantage of the fast and
random frame-to-frame movement of blood speckles in contrast to the slow and
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consistent motion from the tissue [95;96]. This motion contrast is also the most important
visual cue to physicians unless saline is injected to flush out the lumen. One common
drawback of a motion-based method is its inability to detect blood speckle effectively at
low flow velocities, which is often seen in severe flow-limiting lesions. Other clinical
applications, such as identifying small dissections, thrombi, or mild stent malappositions
may also require dealing with a low flow condition where blood speckle does not always
present a clear motion contrast. The unique advantage of the multi-frequency approach is
that it does not rely on blood-tissue motion differences and, as demonstrated by the
results in Error! Reference source not found., this method was able to enhance the lumen
even when there was no blood flow (stagnant flow) in the phantom. Furthermore, this
method does not require processing image data from multiple vectors or multiple frames,
allowing it to be free of motion-induced smearing artifacts that may hinder a motionbased method.
One limitation of this method is the inhomogeneous image intensity due to the
nature of ultrasound imaging. The MFSR value may vary significantly due to intensity
variation of the speckle. Spatial averaging may be necessary to reduce this variation but it
may also limit the resolution of the MFSR image.
The multi-frequency processing technique verified that the backscatter power
from blood is proportional to frequency as reported by other groups, where tissue does
not seem to have the same response. In fact, it was found that at 60 MHz the tissue had
been greatly attenuated, whereas the blood scatter power increased. At low shear rates
(≤5 cm/s), the MFSR for blood was approximately 9x greater than the ratio for tissue.
Furthermore, at high shear rates (≥20 cm/s), the MFSR for blood was an average of 7x
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greater than the MFSR for tissue. This effect provides a feasible method for lumen
enhancement, allowing physicians to better assess the blood-wall boundary and
determine the severity of atherosclerotic region. Although tissue-mimicking media is
designed to model in vivo tissue, there are a lot of dynamics that affect the attenuation of
ultrasound and it would be beneficial to collect RF data from in vivo studies to better
determine the accuracy of the multi-frequency technique described in this paper.
The experimental technique described in this paper has the potential of being
applied to flow velocity measurements. It was found that the MFSR decreased with
velocity; however, further research needs to be performed on velocities greater than 30
cm/s.
As mentioned in previous sections, blood backscatter relies on many factors other
than the flow velocity. It is recommended that further research be developed to
understand whether or not the method proposed in this report would be clinically
acceptable. Currently, detecting thrombus in IVUS is difficult as it has similar acoustic
properties as an atheroma with high lipid content [97]. The MFSR technique, during undocumented tests, indicated the detection of thrombus, which is a serious risk factor when
diagnosing a patient. Further studies to ensure validity of these findings should be
considered.
As center frequencies increase to improve image resolution, more work on multifrequency processing at higher frequencies needs to be addressed since blood scattering
may become so intense that it will then interfere with disease identification.
Furthermore, flow velocity became apparent when analyzing the results during
the study. Further work involving the MFSR technique to help estimate flow velocities
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would significantly aid the characterization of disease within a vessel. If it was estimated
that a low flow state was detected, then one might assume that the severity of the disease
is significant and would require further investigation of the vessel.
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Figure 22: Enhanced Image Analysis: Standard 40 MHz IVUS image (Left). 25 MHz filtered image (Middle). 60 MHz filtered image (Right). This comparison
clearly distinguishes the porcine blood at high frequencies and tissue at lower frequencies.

The IVUS images above can be hard to understand if you are not familiar with IVUS technology. The image on the far left has
not been post-processed in any way. Looking at this image you will notice in the very center a gray circle with bright rings around it
(see Yellow arrow). This whole area is due to the catheter sheath that covers the transducer within the catheter. Essentially, this gray
circle and bright concentric rings surrounding it can be ignored as they are not important when looking at IVUS images. When looking
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at the rest of the image you will notice regions that are brighter than others (see Blue arrow). These regions correspond to normal
tissue within the coronary arteries. Normal tissue is characterized by having a good scattering effect and long rod-like shapes. The red
arrow indicates the region in which blood flows. The backscatter level here is typically lower than tissue and its texture much more
fine than normal tissue – it can be better described as looking at static while watching TV.
The middle image is a representation of the image on the far left, except this image has been post-processed and filtered at
25MHz. This means only data within 25MHz will be present in the image. We can see from this image that tissue is more prominent
and has a higher backscatter response at lower frequencies (see the Blue arrow), whereas blood is barely visible in this image. The far
right image has been processed at 60MHz. Here it is evident that the blood is the most prominent scattering element in the image (see
Red arrow) – it is also apparent that the tissue has been filtered. The difference between these two images is the essence of how the
MFSR value is calculated and what enables the enhancement of the lumen boundary.
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